Ranbaxy Laboratories has received approval to manufacture and market sertraline HCl tablets in base strengths of 25, 50, 100, 150, and 200 mg.
The Ranbaxy formulation is bioequiv-alent to, and has the same therapeutic effect as that of, Zoloft generic (Pfizer) tablets in these doses.
Sertraline drug is indicated for the treatment of Major Depressive Disorder.
ABILIFY (Aripiprazole) drug was developed by two companies: Otsuka Pharmaceutical Co., Ltd and Bristol-Myers Squibb Company. In 2004 Abilify medicine was approved in for treating schizophrenia disease and in 2008 it was ratified as medicine for bipolar disorder.
It has been known today that the U.S. Food and Drug Administration (FDA) [...]
Risperdal drug (Risperidone) is an oral prescription medication that has been approved in the UK for the treatment of mania in bipolar disorder, also known as manic-depression. It causes periods of extreme depression and mania and leads to unusual shifts in a person’s energy, mood and ability to function. This chronic [...]
In a class of antipsychotic drugs generic Lexapro is a useful treatment option for treating depression. A new study was conducted and Forest Laboratories, Inc., (NYSE: FRX) today announced the results.
The randomized, double-blinded study involved patients 18-80 years of age with DSM-IV diagnosed MDD as determined by a Montgomery-Asberg Depression Rating Scale (MADRS) score of [...]
Depression is a chronic disease that requires medical treatment. But there is not a large choice of FDA-approved options to prescribe.
The results of a study presented at the 2008 Annual Meeting of the American Psychiatric Association suggest that Lexapro drug can be a useful antipsychotic medication for adolescents with depression.
